Oxford Immunotec Global PLC (OXFD) Forms $12.45 Double Bottom; VITASOY INTL H 0.25 PAR ORDINARY SHARES (VTSYF) Sellers Decreased By 25.56% Their Shorts

Oxford Immunotec Global PLC (NASDAQ:OXFD) Logo

Oxford Immunotec Global PLC (OXFD) formed double bottom with $11.70 target or 6.00% below today’s $12.45 share price. Oxford Immunotec Global PLC (OXFD) has $322.11M valuation. The stock decreased 0.48% or $0.06 during the last trading session, reaching $12.45. About 75,693 shares traded. Oxford Immunotec Global PLC (NASDAQ:OXFD) has declined 19.42% since March 31, 2017 and is downtrending. It has underperformed by 30.97% the S&P500.

VITASOY INTL H 0.25 PAR ORDINARY SHARES (OTCMKTS:VTSYF) had a decrease of 25.56% in short interest. VTSYF’s SI was 6,700 shares in March as released by FINRA. Its down 25.56% from 9,000 shares previously. With 10,700 avg volume, 1 days are for VITASOY INTL H 0.25 PAR ORDINARY SHARES (OTCMKTS:VTSYF)’s short sellers to cover VTSYF’s short positions. It closed at $2.52 lastly. It is down 0.00% since March 31, 2017 and is . It has underperformed by 11.55% the S&P500.

Vitasoy International Holdings Limited, together with its subsidiaries, makes and sells food and beverages. The company has market cap of $2.68 billion. It offers soya milk, tea, water, juice, tofu, rice milk, pasta, soy related products, etc. It has a 37.61 P/E ratio. The firm offers its products primarily under the VITASOY brand.

Among 4 analysts covering Oxford Immunotec (NASDAQ:OXFD), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Oxford Immunotec has $22.0 highest and $15.0 lowest target. $17.75’s average target is 42.57% above currents $12.45 stock price. Oxford Immunotec had 10 analyst reports since July 19, 2017 according to SRatingsIntel. The rating was maintained by Cowen & Co with “Buy” on Tuesday, October 31. Cowen & Co maintained Oxford Immunotec Global PLC (NASDAQ:OXFD) on Wednesday, July 19 with “Buy” rating. The rating was maintained by Piper Jaffray on Monday, January 8 with “Buy”. Cowen & Co maintained it with “Buy” rating and $19.0 target in Wednesday, August 16 report. The firm has “Buy” rating given on Thursday, September 28 by BTIG Research. Robert W. Baird maintained Oxford Immunotec Global PLC (NASDAQ:OXFD) on Thursday, October 19 with “Buy” rating. Robert W. Baird maintained Oxford Immunotec Global PLC (NASDAQ:OXFD) rating on Tuesday, October 31. Robert W. Baird has “Buy” rating and $20.0 target. The rating was maintained by Cowen & Co on Monday, January 22 with “Buy”. Cowen & Co maintained the stock with “Buy” rating in Wednesday, September 27 report.

Analysts await Oxford Immunotec Global PLC (NASDAQ:OXFD) to report earnings on May, 1. They expect $-0.38 earnings per share, down 5.56% or $0.02 from last year’s $-0.36 per share. After $-0.34 actual earnings per share reported by Oxford Immunotec Global PLC for the previous quarter, Wall Street now forecasts 11.76% negative EPS growth.

Investors sentiment increased to 1.57 in Q4 2017. Its up 0.44, from 1.13 in 2017Q3. It increased, as 11 investors sold Oxford Immunotec Global PLC shares while 17 reduced holdings. 13 funds opened positions while 31 raised stakes. 23.93 million shares or 6.29% more from 22.51 million shares in 2017Q3 were reported. Millennium Ltd Limited Liability Company owns 182,605 shares. Penn Capital Mgmt Co has 0.21% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD) for 212,868 shares. Neuberger Berman Grp Inc Ltd has 99,106 shares. Nebraska-based Ameritas Invest Prtnrs Inc has invested 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD). The New York-based Comml Bank Of Mellon Corp has invested 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD). Moreover, State Common Retirement Fund has 0% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD). Grandeur Peak Glob Advisors Ltd Liability Company owns 1.42% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD) for 783,203 shares. California State Teachers Retirement holds 0% in Oxford Immunotec Global PLC (NASDAQ:OXFD) or 39,908 shares. 60,373 were reported by Morgan Stanley. Kennedy Mngmt Inc, a Missouri-based fund reported 98,912 shares. Moreover, Utd Services Automobile Association has 0.01% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD). Point72 Asset Management Lp owns 0.03% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD) for 506,400 shares. Moreover, Tiverton Asset Mngmt Limited Liability has 0.1% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD) for 116,666 shares. Northern Tru owns 267,709 shares for 0% of their portfolio. Moreover, Royal Fincl Bank Of Canada has 0% invested in Oxford Immunotec Global PLC (NASDAQ:OXFD).

Since October 2, 2017, it had 0 insider buys, and 1 insider sale for $36,038 activity. 55,000 shares were sold by Wrighton-Smith Peter, worth $922,933. SANDBERG RICHARD A also sold $36,038 worth of Oxford Immunotec Global PLC (NASDAQ:OXFD) shares.

Oxford Immunotec Global PLC (NASDAQ:OXFD) Ratings Chart